Quantcast

Latest pharmaceutical industry Stories

2014-07-29 16:26:09

ARLINGTON, Va., July 29, 2014 /PRNewswire-USNewswire/ -- HDMA President and CEO John M. Gray released the following statement on today's passage of the Ensuring Patient Access and Effective Drug Enforcement Act of 2014 (H.R. 4709) by the House of Representatives. The legislation is sponsored by Reps. Tom Marino (R-Pa.), Marsha Blackburn (R-Tenn.), Peter Welch (D-Vt.) and Judy Chu (D-Calif.) "Today's vote represents a victory for those working to curb our nation's prescription drug...

2014-07-29 12:35:35

TAMPA, Fla., July, 29 2014 /PRNewswire-USNewswire/ -- ISPE--the International Society for Pharmaceutical Engineering announced today it has hired John Bournas as President and CEO, succeeding Nancy Berg who announced plans to leave the Society last fall. Mr. Bournas takes the helm at ISPE with extensive competencies in the healthcare association industry as well as significant international experience. He brings to the Society a clear vision for the expansion of its global...

2014-07-29 08:34:18

New pharmaceutical development opens up entry into blockbuster markets SALT LAKE CITY and TORONTO, July 29, 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development of improved novel formulations and alternative dosage forms of existing biologically active molecules announces expansion of its pharmaceutical development implementing its sub-micron platform technology. The company's...

2014-07-29 08:32:54

Phase I Project to Focus on Advanced Molecular Search Models for the Inverse Design Computational Drug Discovery Platform RESEARCH TRIANGLE PARK, N.C., July 29, 2014 /PRNewswire/ -- Cloud Pharmaceuticals, Inc., a therapeutics company focused on cloud-based drug design and development, announced today that it has been awarded a Phase I grant from the National Science Foundation Small Business Innovation Research (NSF SBIR) program. The grant is valued at $150,000. Cloud...

2014-07-29 08:32:31

HAYWARD, Calif., July 29, 2014 /PRNewswire/ -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Food and Drug Administration (FDA) performed a general GMP inspection and a Pre-Approval Inspection (PAI) for RYTARY(TM )at the Company's Taiwan manufacturing facility from July 21 to July 26, 2014. At the conclusion of the inspection, the FDA issued a Form 483 with ten inspectional observations. The Taiwan facility was approved for product manufacturing by the FDA in...

2014-07-29 08:32:30

BELLEVILLE, ON, July 29, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced the submission to the US Food and Drug Administration (FDA) Office of Orphan Products Development, an application for Orphan Drug Designation for its Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory/relapsing high grade non-muscle invasive bladder cancer. The decision to proceed...

2014-07-28 23:04:08

Transparency Market Research has published a new report titled "Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/e-clinical-solution-software-market.html. Albany, New York (PRWEB) July 28, 2014 According to a new market report published by Transparency Market Research "E-Clinical Solution Software Market- Global Industry...

2014-07-28 20:25:54

BOSTON, July 28, 2014 /PRNewswire/ -- Hays Companies of Boston is pleased to announce Melissa Tobler is one of four individuals to date to receive the Validation Institute's Advanced Certification on Critical Outcomes Report Analysis. Intel-GE Care Innovations(TM) launched the Validation Institute to "challenge the status quo of typical healthcare research design principles, with the goal of positively impacting how the industry establishes credibility over time, but also ultimately...

2014-07-28 16:27:20

LONDON, July 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Global Transdermal Drug Delivery Market 2014-2018https://www.reportbuyer.com/product/2225684/Global-Transdermal-Drug-Delivery-Market-2014-2018.htmlAbout Transdermal Drug DeliveryTransdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration into the...

2014-07-28 08:28:49

TORONTO, July 28, 2014 /PRNewswire/ - Lorus Therapeutics Inc. (TSX: LOR) today announced that the Food and Drug Administration (FDA) completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma. Clearance of the IND allows Lorus to initiate a Phase 1b, multi-center, open-label,...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related